|
14 Apr 2025 |
Bata
|
Consensus Share Price Target
|
1241.85 |
1326.53 |
- |
6.82 |
hold
|
|
|
|
|
13 Feb 2025
|
Bata
|
IDBI Capital
|
1241.85
|
1561.00
|
1333.70
(-6.89%)
|
25.70 |
Buy
|
|
|
|
|
13 Feb 2025
|
Bata
|
Axis Direct
|
1241.85
|
1320.00
|
1333.70
(-6.89%)
|
Target met |
Hold
|
|
|
With a 2% downside from the CMP, we maintain our HOLD rating on the stock
|
|
11 Nov 2024
|
Bata
|
IDBI Capital
|
1241.85
|
1610.00
|
1330.90
(-6.69%)
|
29.65 |
Buy
|
|
|
|
|
11 Nov 2024
|
Bata
|
Axis Direct
|
1241.85
|
1290.00
|
1330.90
(-6.69%)
|
Target met |
Hold
|
|
|
With a 3% downside from the CMP, we maintain our HOLD rating on the stock.
|
|
10 Nov 2024
|
Bata
|
Motilal Oswal
|
1241.85
|
1240.00
|
1336.30
(-7.07%)
|
Target met |
Neutral
|
|
|
Bata India (BATA) delivered a modest growth recovery with 2% YoY revenue growth. The 10% miss on EBITDA was primarily driven by lower gross margin (-140bp YoY) on account of a shift in the channel mix.
|
|
09 Aug 2024
|
Bata
|
Axis Direct
|
1241.85
|
1380.00
|
1443.00
(-13.94%)
|
Target met |
Hold
|
|
|
With a 5% downside potential from the CMP, we maintain our HOLD rating on the stock.
|
|
08 Aug 2024
|
Bata
|
Sharekhan
|
1241.85
|
1560.00
|
1455.70
(-14.69%)
|
25.62 |
Hold
|
|
|
Bata India’s (Bata’s) Q1FY2025 numbers were weak, with revenues declining by 1.4% y-o-y, and EBITDA margin falling by 393 bps y-o-y to 21.2%, dragging down adjusted PAT by 27.5% y-o-y.
|
|
10 Jun 2024
|
Bata
|
Geojit BNP Paribas
|
1241.85
|
1686.00
|
1482.70
(-16.24%)
|
35.77 |
Accumulate
|
|
|
|
|
03 Jun 2024
|
Bata
|
IDBI Capital
|
1241.85
|
1610.00
|
1368.45
(-9.25%)
|
Target met |
Buy
|
|
|
|
|
03 May 2024
|
Bata
|
Axis Direct
|
1241.85
|
1470.00
|
1368.45
(-9.25%)
|
Target met |
Hold
|
|
|
With an 8% upside potential from the CMP, we maintain our HOLD rating on the stock.
|
|
12 Mar 2024
|
Bata
|
Geojit BNP Paribas
|
1241.85
|
1670.00
|
1427.05
(-12.98%)
|
|
Accumulate
|
|
|
|
|
07 Feb 2024
|
Bata
|
IDBI Capital
|
1241.85
|
1784.00
|
1421.45
(-12.63%)
|
|
Buy
|
|
|
|
|
07 Feb 2024
|
Bata
|
Axis Direct
|
1241.85
|
1520.00
|
1421.45
(-12.63%)
|
Target met |
Hold
|
|
|
Recommendation: With a 5% upside potential from the CMP, we maintain HOLD
|
|
27 Dec 2023
|
Bata
|
Geojit BNP Paribas
|
1241.85
|
1870.00
|
1639.70
(-24.26%)
|
|
Buy
|
|
|
|
|
10 Nov 2023
|
Bata
|
Motilal Oswal
|
1241.85
|
1430.00
|
1562.65
(-20.53%)
|
Target met |
Neutral
|
|
|
|
|
10 Nov 2023
|
Bata
|
Axis Direct
|
1241.85
|
1650.00
|
1562.65
(-20.53%)
|
Target met |
Hold
|
|
|
With a 5% upside potential from the CMP, we maintain HOLD
|
|
28 Aug 2023
|
Bata
|
Geojit BNP Paribas
|
1241.85
|
1867.00
|
1694.00
(-26.69%)
|
|
Hold
|
|
|
|
|
14 Aug 2023
|
Bata
|
Axis Direct
|
1241.85
|
1780.00
|
1646.90
(-24.59%)
|
|
Hold
|
|
|
Recommendation With a 8% upside potential from the CMP, we downgrade the stock to HOLD
|
|
13 Aug 2023
|
Bata
|
Motilal Oswal
|
1241.85
|
1540.00
|
1649.65
(-24.72%)
|
Target met |
Neutral
|
|
|
|
|
10 Aug 2023
|
Bata
|
ICICI Securities Limited
|
1241.85
|
1650.00
|
1700.30
(-26.96%)
|
Target met |
Hold
|
|
|
BATA’s revenue performance has been decent on SSSG front (-9% our estimate vs -12% for Metro) while retail expansion (at 11%) continues to be modest. Revenue growth at 2% YoY is un-exciting. Improvement in ASP (3%YoY) instills confidence in the execution of casualisation and premiumisation initiatives.
|